Carmustine and methotrexate in combination after whole brain radiation therapy in breast cancer patients presenting with brain metastases: a retrospective study

BACKGROUND: Since 1999, patients presenting with brain metastases (BM) from breast cancer (BC) are treated in our institution with a carmustine (BCNU) - methotrexate (MTX) combination. We report here our clinical experience regarding this combination. PATIENTS AND METHODS: Patients were treated by a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacot, William, Gerlotto-Borne, Marie-Cécile, Thezenas, Simon, Pouderoux, Stéphane, Poujol, Sylvain, About, Mahdi, Romieu, Gilles
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887781/
https://www.ncbi.nlm.nih.gov/pubmed/20525352
http://dx.doi.org/10.1186/1471-2407-10-257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887781/
https://www.ncbi.nlm.nih.gov/pubmed/20525352
http://dx.doi.org/10.1186/1471-2407-10-257

Ejemplares similares